The New Delhi Centre for Sight (CFS) is expected to receive an investment of upto $100 million from ChrysCapital.
The transaction will be done by way of a primary infusion in CFS and through secondary acquisition of the entire stake held by Mahindra Holdings Limited.
DMD Advocates advised CFS on this investment by drafting and negotiation of the transaction documents, as well as in conducting a vendor legal due diligence of CFS, its subsidiaries and the centres operated by CFS.
The transaction was led by Rashi Dhir (Senior Partner and Head of Corporate) along with Saiyam Chaturvedi (Partner), Kajal Tandon (Counsel), Divay Rastogi (Counsel), Priyanka Hazarika (Senior Associate), Arnav Mithal (Associate), and Srishti Pandey (Associate).
Aishwarya Gupta (Senior Associate), Aditi Kumari (Associate), Ela Bharti (Associate), Jasmine Brar (Associate), and Tarush Bhandari (Associate) assisted the transaction team in the vendor due diligence exercise.
Founded in 1996 by Prof. Dr. Mahipal S. Sachdev, Centre for Sight has over 350 experienced doctors and a network of 85+ centers across the country.
The Centre for Sight Eye Institute in Dwarka, Delhi, is North India's largest private super-specialty eye hospital. Registered under the Nursing Home Act in multiple states and accredited by NABH.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.